Chemoendocrine Therapy Not Superior to Tamoxifen Plus OFS in Node-Positive Breast Cancer
A retrospective study finds no significant difference in recurrence-free survival between chemoendocrine therapy and tamoxifen plus ovarian function suppression in ...

